144 ·Filed Jun 22, 2026

GH

Guardant Health, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001921094-26-000676
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine director sale tied to equity compensation. The 1,556-share amount is negligible relative to the $17.5B market cap. No material signal for the stock. Monitor for any subsequent Form 4 filings to confirm execution, but this is not a red flag.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
GH ▲ +33.68% at T+60d
NEUTRAL call ✓ call won +33.68% · α vs SPY +30.44% · entry $130.83 → $174.90
Entry anchored
Jun 22, 03:59 PM ET
via exchange tick
T+1d
+4.69%
call +4.69% · α +4.73%
$136.96
settled 3mo ago
T+5d
+17.51%
call +17.51% · α +16.50%
$153.74
settled 3mo ago
T+20d
+13.18%
call +13.18% · α +12.02%
$148.07
settled 2mo ago
T+60d
+33.68%
call +33.68% · α +30.44%
$174.90
settled 16d ago

Price Chart

Loading chart...

Executive Summary

Myrtle S. Potter, a Director of Guardant Health, filed a Form 144 on 2026-06-22 to sell 1,556 shares of common stock, with an estimated aggregate market value of approximately $204,085. The shares were acquired via a restricted stock lapse on 2026-06-18, indicating this is a routine equity-compensation-related sale.

Key Facts

  • Insider: Myrtle S. Potter, a Director of Guardant Health
  • Proposed sale: 1,556 shares of common stock
  • Estimated value: ~$204,085 (based on $132.60/share reference price)
  • Shares acquired on 2026-06-18 via restricted stock lapse (equity compensation)
  • Form 144 filed on 2026-06-22, indicating intent to sell in the near future
  • Sale represents a very small fraction of the company's $17.5B market cap

Financial Impact

~$204,085 (1,556 shares at ~$132.60/share)

dilution

Risk Factors

  • No material risk — this is a standard insider sale for tax/compensation purposes

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
91% bullish (32 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001921094-26-000676
Document: 0001921094-26-000676-index.html0001921094-26-000676
Document: 0001921094-26-000676.txt0001921094-26-000676
26 reports for GH
Performance horizon
25% Hit rate 1 of 4 directional calls best @ T+60▲ +31.56%May 27, 2026
Filters
Rows
Reports for GH — sortable, filterable
TypeNow
Aug 24, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$163.18 $177.16▲ +8.57%▲ +7.25%$177.80 (+8.96%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$157.21 $167.84▲ +6.76%▲ +8.75%$177.80 (+13.10%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$157.21 $167.84▲ +6.76%▲ +8.75%$177.80 (+13.10%)
Aug 11, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$165.11 $159.03▼ −3.68%▼ −1.78%$177.80 (+7.69%)
Aug 11, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$165.11 $159.03▼ −3.68%▼ −1.78%$177.80 (+7.69%)
Aug 6, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$168.48 $161.41▼ −4.20%▼ −3.80%$177.80 (+5.53%)
Jul 30, 2026
9w ago
S-3ASR
NEUTRAL ★ 2/10
$161.99 $161.49▼ −0.31%▼ −3.29%$177.80 (+9.76%)
Jun 30, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$170.77 $144.07▼ −15.64%▼ −13.45%$177.80 (+4.12%)
Jun 22, 2026
14w ago
144
NEUTRAL ★ 2/10
$130.83 $148.07▲ +13.18%▲ +12.02%$177.80 (+35.90%)
Jun 16, 2026
15w ago
Court Ruling
BEARISH ★ 7/10
$127.34 $160.11▼ −25.73%▼ −25.53%$177.80 (−39.63%)
Showing 10 of 26

US Market Status

Market Closed — Opens Mon (64h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access